An open, non-comparative study to evaluate the efficacy and tolerability of 2% hydroquinone as a depigmenting agent in the treatment of melasma;Estudo aberto, nao comparativo, da eficacia e tolerabilidade da hidroquinona a 2%, como agente despigmentante, em melasmas

Revista Brasileira de Medicina

Volumn 55, Issue 5, 1998, Pages 351-355

  Minelli, Lorivaldo ^a  

^a Ctro Cie da Saude da Univ E

Author keywords

Hydroquinone; Melasma

Indexed keywords

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; CLARIDERM; HYDROQUINONE; OXYBENZONE; SUNSCREEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL TRIAL; DEPIGMENTATION; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0031801901     PISSN: 00347264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. nd. London. Gower Medical Publishing. 1993, p. 9.2, 25 4.
2. Boyle J, Kennedy CTC - Hydroquinone concentrations in skin lightening creams. Br J Dermatol, 114: 501-504, 1986.
3. Madhu A et al. - Usefulness of retinoic acid in the treatment of melasma. Am Acad Dermatol. 15(4 pt 2): 894-899, 1986.
4. Grimes PE. - Melasma - etiologic and therapeutic considerations. Arch Dermatol, 131: 1453-1457, 1995.
5. Gano SE, Garcia RL. - Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma. Cutis, 23(2): 239-241, 1979.
6. Kligman AM, Willis I - A new formula for depigmenting human skin Arch Dermatol. 111(1). 40-48, 1975
7. Engasser PG, Maibach HI. - Cosmetics and dermatology: bleaching creams. J Am Acad Dermatol, 5: 143-147, 1981.
8. Pathak MA et al. - Treatment of melasma with hydroquinone J Inv Dermatol, 76 324, 1981
9. Hemsworth BN - Biological changes due to topical application of skin lightening compounds. J Soc Chem, 24: 727-733, 1973
10. Arndt KA, Fitzpatrick TB. - Topical use of hydroquinone as a depigmenting agent Jama, 194: 965-967, 1965.
11. Spencer MC. - Topical use of hydroquinone for depigmentation. JAMA, 194(9): 114-116, 1965
12. nd ed . Montvale. Medical Economics, 1996, p 1635.
13. Vàzquez M, Sánchez JL - The efficacy of a broadspectrum sunscreen in the treatment of melasma. Cutis. 32(1): 92-96, 1983.
14. st ed., London, Royal Pharmaceutical Society, 1996, p. 1086-1087.
15. a ed , Sāo Paulo, Editora Artes Médicas. 1983, p 219-220, 434-435, 504.
16. Sánchez JL, Vázquez M - A hydroquinone solution in the treatment of melasma. Int J Dermatol, 21(1). 55-58, 1982.
17. Jimbow K et al - Mechanism of depigmentation by hydroquinone J Inv Dermatol, 62: 436-449, 1974.
18. Penney KB et al. - Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Inv Dermatol, 82: 308-310, 1984.
19. Hardwick N et al. Exogenous ochronosis: an epidemiological study. Br J Dermatol, 120: 229-238, 1989.
20. Engasser PG. - Ochronosis caused by bleaching creams. J Am Acad Dermalol, 10(6). 1072-1073, 1984.
21. Hoshaw RA et al. - Ochronosislike pigmentation from hydroquinone bleaching creams in american blacks Arch Dermatol, 121(1): 105-108, 1985.
22. Williams H. Skin lightening creams containing hydroquinone. Br Med J, 305: 903-904, 1992.
23. Mann RJ, Harman RRM. - Nail staining due to hydroquinone skin-lightening creams. Br J Dermatol, 108: 363-365, 1983.
24. a ed , San Salvador. UCA Editores, 1987, p. 289-290.
25. a ed , Rio de Janeiro. Guanabara Koogan, 1985, p.202.
26. a ed., Sāo Paulo, Livraria Atheneu Editora, 1990, p 379
27. Havens MB, Tramposch KM. - Hydroquinone inhibits tyrosinase activity by acting as an alternative substrate J Invest Dermatol, 87: 409, 1986.
28. Palumbo A et al - Skin depigmentation by hydroquinone: a chemical and biochemical insight Pigment Cell Res, Suppl 2: 299-303, 1992.